Persistent T cell activation and cytotoxicity against glioblastoma following single oncolytic virus treatment in a clinical trial

Maxime Meylan(Dana-Farber Cancer Institute), Kai W. Wucherpfennig(Dana-Farber Cancer Institute), Alexander Ling(Centre for Quantum Technologies), Mario L. Suvà(Broad Institute), Graham L. Barlow(Dana-Farber Cancer Institute), Sascha Marx(Dana-Farber Cancer Institute), Jason W. Pyrdol(Dana-Farber Cancer Institute), Daniel Kovarsky(Weizmann Institute of Science), Lucas Westphal(Dana-Farber Cancer Institute), Lijian Wu(Tsinghua University), Linh Dieu Nguyen(Dana-Farber Cancer Institute), Sydney Dumont(Broad Institute), Julius Michel(German Cancer Research Center), E. Antonio Chiocca(Center for Neuro-Oncology), Ye Tian(Dana-Farber Cancer Institute), L. Nicolas Gonzalez Castro(Broad Institute), Andres Santos(Center for Neuro-Oncology), Itay Tirosh(Weizmann Institute of Science)
Cell
February 11, 2026
Cited by 10


Related Papers